Asia Pacific Genetic Testing Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The Asia Pacific genetic testing services market is projected to grow significantly, reaching an estimated US$ 2,550.10 million by 2031, up from US$ 728.38 million in 2023. This growth represents a compound annual growth rate (CAGR) of 17.0% from 2023 to 2031.

Executive Summary and Market Analysis

The genetic testing services market in the Asia Pacific (APAC) region is experiencing rapid expansion, driven by several factors including increased healthcare investments, advancements in technology, and heightened awareness of genetic disorders. Key countries such as China, India, Japan, and South Korea are witnessing a notable rise in demand for genetic testing, particularly in areas such as cancer diagnosis, prenatal screening, and the identification of rare genetic diseases. The growth of personalized medicine, alongside advancements in genomic research, is further propelling the market forward. Additionally, government initiatives aimed at improving healthcare infrastructure and promoting genetic research are expected to bolster ongoing market development. The presence of major industry players is also fostering innovation and enhancing accessibility within the region.

Market Segmentation Analysis

The genetic testing services market can be segmented based on service type, disease, and service provider.

1. Service Type: The market is divided into several categories, including predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic genetic testing, and others. In 2023, the predictive testing segment held the largest market share.

2. Disease: The market is also segmented by disease type, including cancer, cardiovascular diseases, metabolic diseases, and other conditions. The cancer segment was the largest contributor to the market in 2023.

3. Service Provider: The market is categorized by service provider type, which includes hospital-based laboratories, diagnostic laboratories, and other providers. Hospital-based laboratories accounted for the largest share of the market in 2023.

Market Outlook

The increasing prevalence of genetic diseases globally is a significant concern, as these conditions can severely impact health. Genetic diseases often present with uncommon symptoms and are frequently non-curable. Many of these diseases are rare and arise from mutations in individuals' genetic makeup. According to the World Health Organization (WHO) in 2021, approximately 10 out of every 1,000 individuals are affected by single-gene diseases, indicating that between 70 million and 80 million people worldwide are living with such conditions. The Global Genes organization has identified around 7,000 rare diseases and disorders, with new ones being discovered regularly.

Research from the University of Sheffield estimates that around 300 million people globally are affected by genetic diseases. A report from MJH Life Sciences in 2022 highlighted that approximately 300,000 newborns are diagnosed with sickle cell disease each year, representing about 5% of the global population.

In the Asia Pacific and Middle East regions, a significant number of individuals are diagnosed with genetic diseases, partly due to the prevalence of consanguineous marriages in many communities. Such marriages contribute to the rising incidence of genetic disorders, thereby increasing the demand for genetic testing services, which in turn drives market growth.

Country Insights

The Asia Pacific genetic testing services market includes several key countries: China, Japan, India, Australia, South Korea, and others. China held the largest market share in 2023.

In recent years, awareness of the benefits of genetic testing has significantly increased in China. The availability of direct-to-consumer (DTC) tests has improved convenience and accessibility, positively influencing market growth. Chinese scientists and authorities have emphasized the potential of genetic material in studying and treating diseases, developing pharmaceuticals, and understanding congenital disabilities.

According to a study titled "Spotlight on Gene Therapy in China," published in July 2020, over 57 million individuals in China suffer from genetic diseases, with approximately 4 million new cancer cases reported annually. The Global Cancer Observatory reported a total of 4,568,754 cancer cases in China in 2020. Furthermore, an article published in February 2023 noted that around 20 million people in China are affected by rare diseases.

The shift from a one-child policy to a universal two-child policy in China is expected to increase the number of births, thereby enhancing the demand for newborn genetic testing. Additionally, the Precision Medicine Initiative, launched by the Chinese Academy of Sciences in 2016, aims to sequence over 100 million human genomes by 2030, with a budget of US$ 9.2 billion. In July 2021, BGI Group, a Chinese gene company, developed a prenatal test in collaboration with the military, which collects genetic data from millions of women for extensive research on traits and abnormalities such as Down syndrome. These factors are anticipated to significantly drive the growth of the genetic testing services market in China.

Company Profiles

Key players in the Asia Pacific genetic testing services market include Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, and GeneDx, LLC, among others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Product Code: BMIRE00030242

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Asia Pacific Genetic Testing Services Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Genetic Diseases
- 4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
- 4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
4.2 Market Restraints
- 4.2.1 Social and Ethical Implications of Genetic Testing
- 4.2.2 Affordability of Genetic Services
4.3 Market Opportunities
- 4.3.1 Untapped Emerging Markets in Developing Countries
4.4 Future Trends
- 4.4.1 Artificial Intelligence-Powered Genetic Testing
4.5 Impact Analysis:

5. Genetic Testing Services Market - Asia Pacific Analysis

5.1 Asia Pacific Genetic Testing Services Market Revenue (US$ Million), 2021-2031
5.2 Asia Pacific Genetic Testing Services Market Forecast Analysis

6. Asia Pacific Genetic Testing Services Market Analysis - by Service Type

6.1 Predictive Testing
- 6.1.1 Overview
- 6.1.2 Predictive Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Carrier Testing
- 6.2.1 Overview
- 6.2.2 Carrier Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Prenatal Testing
- 6.3.1 Overview
- 6.3.2 Prenatal Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.4 New-born Screening
- 6.4.1 Overview
- 6.4.2 New-born Screening: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.5 Diagnostic Genetic Testing
- 6.5.1 Overview
- 6.5.2 Diagnostic Genetic Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Asia Pacific Genetic Testing Services Market Analysis - by Disease

7.1 Cancer
- 7.1.1 Overview
- 7.1.2 Cancer: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Cardiovascular Diseases
- 7.2.1 Overview
- 7.2.2 Cardiovascular Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Metabolic Diseases
- 7.3.1 Overview
- 7.3.2 Metabolic Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Other Diseases
- 7.4.1 Overview
- 7.4.2 Other Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Genetic Testing Services Market Analysis - by Service Providers

8.1 Hospital-Based Laboratories
- 8.1.1 Overview
- 8.1.2 Hospital-Based Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Diagnostic Laboratories
- 8.2.1 Overview
- 8.2.2 Diagnostic Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Other Service Providers
- 8.3.1 Overview
- 8.3.2 Other Service Providers: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Genetic Testing Services Market - Country Analysis

9.1 Asia Pacific
- 9.1.1 Asia Pacific Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 Asia Pacific Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.2.1 China: Asia Pacific Genetic Testing Services Market Share - by Service Type
    - 9.1.1.2.2 China: Asia Pacific Genetic Testing Services Market Share - by Disease
    - 9.1.1.2.3 China: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
    - 9.1.1.2.4 China: Asia Pacific Genetic Testing Services Market Share - by Service Providers
  - 9.1.1.3 Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.3.1 Japan: Asia Pacific Genetic Testing Services Market Share - by Service Type
    - 9.1.1.3.2 Japan: Asia Pacific Genetic Testing Services Market Share - by Disease
    - 9.1.1.3.3 Japan: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
    - 9.1.1.3.4 Japan: Asia Pacific Genetic Testing Services Market Share - by Service Providers
  - 9.1.1.4 India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.4.1 India: Asia Pacific Genetic Testing Services Market Share - by Service Type
    - 9.1.1.4.2 India: Asia Pacific Genetic Testing Services Market Share - by Disease
    - 9.1.1.4.3 India: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
    - 9.1.1.4.4 India: Asia Pacific Genetic Testing Services Market Share - by Service Providers
  - 9.1.1.5 Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.5.1 Australia: Asia Pacific Genetic Testing Services Market Share - by Service Type
    - 9.1.1.5.2 Australia: Asia Pacific Genetic Testing Services Market Share - by Disease
    - 9.1.1.5.3 Australia: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
    - 9.1.1.5.4 Australia: Asia Pacific Genetic Testing Services Market Share - by Service Providers
  - 9.1.1.6 South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.6.1 South Korea: Asia Pacific Genetic Testing Services Market Share - by Service Type
    - 9.1.1.6.2 South Korea: Asia Pacific Genetic Testing Services Market Share - by Disease
    - 9.1.1.6.3 South Korea: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
    - 9.1.1.6.4 South Korea: Asia Pacific Genetic Testing Services Market Share - by Service Providers
  - 9.1.1.7 Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.7.1 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Service Type
    - 9.1.1.7.2 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Disease
    - 9.1.1.7.3 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
    - 9.1.1.7.4 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Service Providers

10. Genetic Testing Services Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in Genetic Testing Services Market
10.3 Organic Growth Strategies
- 10.3.1 Overview
10.4 Inorganic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Eurofins Scientific SE
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Exact Sciences Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Laboratory Corp of America Holdings
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4andMe Holding Co
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Ambry Genetics Corp
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Quest Diagnostics Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Illumina Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 F. Hoffmann-La Roche Ltd
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 NeoGenomics Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Centogene NV
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 Ancestry Genomics Inc
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
11.12 Gene By Gene Ltd
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
11.13 SIVOTEC BioInformatics LLC
- 11.13.1 Key Facts
- 11.13.2 Business Description
- 11.13.3 Products and Services
- 11.13.4 Financial Overview
- 11.13.5 SWOT Analysis
- 11.13.6 Key Developments
11.14 Progenesis
- 11.14.1 Key Facts
- 11.14.2 Business Description
- 11.14.3 Products and Services
- 11.14.4 Financial Overview
- 11.14.5 SWOT Analysis
- 11.14.6 Key Developments
11.15 Fulgent Genetics, Inc
- 11.15.1 Key Facts
- 11.15.2 Business Description
- 11.15.3 Products and Services
- 11.15.4 Financial Overview
- 11.15.5 SWOT Analysis
- 11.15.6 Key Developments
11.16 VERITAS INTERCONTINENTAL
- 11.16.1 Business Description
- 11.16.2 Products and Services
- 11.16.3 Financial Overview
- 11.16.4 SWOT Analysis
- 11.16.5 Key Developments
11.17 GeneDx, LLC
- 11.17.1 Key Facts
- 11.17.2 Business Description
- 11.17.3 Products and Services
- 11.17.4 Financial Overview
- 11.17.5 SWOT Analysis
- 11.17.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms